Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引：0
|
作者：
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构：
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    [J]. CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [2] Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
    Pandit, Saagar A.
    Momenaei, Bita
    Wakabayashi, Taku
    Mansour, Hana A.
    Vemula, Sudheshna
    Durrani, Asad F.
    Pashaee, Bahram
    Kazan, Adina S.
    Ho, Allen C.
    Klufas, Michael
    Regillo, Carl
    Yonekawa, Yoshihiro
    Hsu, Jason
    Kuriyan, Ajay
    Chiang, Allen
    [J]. OPHTHALMOLOGY RETINA, 2024, 8 (04): : 360 - 366
  • [3] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [5] Real-world outcomes for fellow eyes in neovascular age-related macular degeneration
    Aydogmus, Fatma Sema Akkan
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Lasalle, Claudia
    Ramsey, David J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [6] Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands
    Verbraak, Frank D.
    Ponsioen, Dirk L.
    Tigchelaar-Besling, Odette A. M.
    Nguyen, Vuong
    Gillies, Mark C.
    Barthelmes, Daniel
    Klaver, Caroline C. W.
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E884 - E892
  • [7] Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)
    Karamat, Ayesha
    O'Neill, Charles
    Corradetti, Giulia
    Lindenberg, Sophiana
    Tojjar, Jasaman
    Almidani, Louay
    Do, Giang
    Mauger, Stephanie
    Nittala, Muneeswar
    Chauhan, Devinder
    Sadda, SriniVas
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [8] Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
    Ng, Benjamin
    Kolli, Hema
    Kumar, Naduviledeth Ajith
    Azzopardi, Matthew
    Logeswaran, Abison
    Buensalido, Julius
    Mushtaq, Bushra
    Chavan, Randhir
    Chong, Yu Jeat
    [J]. LIFE-BASEL, 2024, 14 (02):
  • [9] Initial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Leung, Ella H.
    Oh, Daniel J.
    Alderson, Shannon E.
    Bracy, Joshlynn
    McLeod, Mia
    Perez, Litzi, I
    Bottini, Alexander
    Yee, David Chin
    Mukkamala, Krishna
    [J]. CLINICAL OPHTHALMOLOGY, 2023, 17 : 1287 - 1293
  • [10] Real-World Weekly Efficacy Analysis of Faricimab in Patients with Age-Related Macular Degeneration
    Muth, Daniel R.
    Fasler, Katrin F.
    Kvanta, Anders
    Rejdak, Magdalena
    Blaser, Frank
    Zweifel, Sandrine A.
    [J]. BIOENGINEERING-BASEL, 2024, 11 (05):
12345